{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:19:01Z","timestamp":1792423141201,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA033679"],"award-info":[{"award-number":["R01 DA033679"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24 DA017072"],"award-info":[{"award-number":["K24 DA017072"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI007517"],"award-info":[{"award-number":["T32 AI007517"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jsat.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T09:08:13Z","timestamp":1548580093000},"page":"18-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support"],"prefix":"10.1016","volume":"100","author":[{"given":"Dharushana","family":"Muthulingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Bia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott O.","family":"Farnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan T.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2019.01.019_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13722-015-0034-5","article-title":"Factors associated with willingness to take extended release naltrexone among injection drug users","volume":"10","author":"Ahamad","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2019.01.019_bb0010","series-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (Update). The CBHSQ report","first-page":"1","author":"Alderks","year":"2013"},{"issue":"9","key":"10.1016\/j.jsat.2019.01.019_bb0015","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1377\/hlthaff.2011.0686","article-title":"Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs","volume":"31","author":"Arterburn","year":"2012","journal-title":"Health Affairs"},{"issue":"6","key":"10.1016\/j.jsat.2019.01.019_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/ADM.0000000000000348","article-title":"Addressing stigma in medication treatment of adolescents with opioid use disorder","volume":"11","author":"Bagley","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2019.01.019_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2015.04.002","article-title":"Patient perspectives associated with intended duration of buprenorphine maintenance therapy","volume":"56","author":"Bentzley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.01.019_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2016.03.003","article-title":"The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment","volume":"66","author":"Bojko","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"49","key":"10.1016\/j.jsat.2019.01.019_bb0040","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1073\/pnas.1518393112","article-title":"Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century","volume":"112","author":"Case","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jsat.2019.01.019_bb0045","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2019.01.019_bb0050","series-title":"National vital statistics system, Mortality","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.jsat.2019.01.019_bb0055","series-title":"Peer review in health sciences","first-page":"219","article-title":"How to peer review a qualitative manuscript","author":"Clark","year":"2003"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pec.2012.11.016","article-title":"Combining deliberation and intuition in patient decision support","volume":"91","author":"de Vries","year":"2013","journal-title":"Patient Education and Counseling"},{"key":"10.1016\/j.jsat.2019.01.019_bb0070","series-title":"Group techniques for program planning--A guide to nominal group and delphi processes","author":"Delbecq","year":"1975"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pec.2010.04.034","article-title":"How to develop web-based decision support interventions for patients: A process map","volume":"82","author":"Elwyn","year":"2011","journal-title":"Patient Education and Counseling"},{"key":"10.1016\/j.jsat.2019.01.019_bb0080","doi-asserted-by":"crossref","first-page":"c5146","DOI":"10.1136\/bmj.c5146","article-title":"Implementing shared decision making in the NHS","volume":"341","author":"Elwyn","year":"2010","journal-title":"BMJ"},{"issue":"7565","key":"10.1016\/j.jsat.2019.01.019_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","article-title":"Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process","volume":"333","author":"Elwyn","year":"2006","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jsat.2019.01.019_bb0090","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1377\/hlthaff.2009.0888","article-title":"Why the nation needs a policy push on patient-centered health care","volume":"29","author":"Epstein","year":"2010","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2019.01.019_bb0095","author":"FDA"},{"issue":"1","key":"10.1016\/j.jsat.2019.01.019_bb0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1369-7625.2006.00420.x","article-title":"A systematic review of information in decision aids","volume":"10","author":"Feldman-Stewart","year":"2007","journal-title":"Health Expectations"},{"issue":"4","key":"10.1016\/j.jsat.2019.01.019_bb0105","first-page":"39","article-title":"Outcomes of opioid-dependence treatment across Europe: Identifying opportunites for improvement","volume":"14","author":"Fischer","year":"2012","journal-title":"Heroin Addiction And Related Clinical Problems"},{"key":"10.1016\/j.jsat.2019.01.019_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2019.01.019_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2017.04.010","article-title":"Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison","volume":"85","author":"Friedmann","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2019.01.019_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.17730\/humo.43.4.64m061v484th3871","article-title":"Methadone folklore: Beliefs about side effects and their impact on treatment","volume":"43","author":"Goldsmith","year":"1984","journal-title":"Human Organization"},{"issue":"1","key":"10.1016\/j.jsat.2019.01.019_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00774-015-0732-9","article-title":"Bone mineral density and its determinants in men with opioid dependence","volume":"35","author":"Gotthardt","year":"2017","journal-title":"Journal of Bone and Mineral Metabolism"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2010.03159.x","article-title":"Decreased bone density in men on methadone maintenance therapy","volume":"106","author":"Grey","year":"2011","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"issue":"1","key":"10.1016\/j.jsat.2019.01.019_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: A qualitative study","volume":"12","author":"Hewell","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"10","key":"10.1016\/j.jsat.2019.01.019_bb0145","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/ACM.0000000000001812","article-title":"The use of the Delphi and other consensus group methods in medical education research: A review","volume":"92","author":"Humphrey-Murto","year":"2017","journal-title":"Academic Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2019.01.019_bb0150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1360-0443.1998.93811776.x","article-title":"Effects of readiness for drug abuse treatment on client retention and assessment of process","volume":"93","author":"Joe","year":"1998","journal-title":"Addiction"},{"issue":"7001","key":"10.1016\/j.jsat.2019.01.019_bb0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jsat.2019.01.019_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2006.10399832","article-title":"Predicting treatment retention with a brief \u201cOpinions About Methadone\u201d scale","volume":"38","author":"Kayman","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.jsat.2019.01.019_bb0165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0272989X09331809","article-title":"Construction of health preferences: A comparison of direct value assessment and personal narratives","volume":"29","author":"Kerstholt","year":"2009","journal-title":"Medical Decision Making"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","article-title":"Low bone density in patients receiving methadone maintenance treatment","volume":"85","author":"Kim","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/add.13673","article-title":"Patient-centred care-perhaps the future of substance abuse treatment","volume":"112","author":"Kolind","year":"2017","journal-title":"Addiction"},{"issue":"9776","key":"10.1016\/j.jsat.2019.01.019_bb0180","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jsat.2019.01.019_bb0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","article-title":"Conducting discrete choice experiments to inform healthcare decision making: A user's guide","volume":"26","author":"Lancsar","year":"2008","journal-title":"PharmacoEconomics"},{"issue":"13","key":"10.1016\/j.jsat.2019.01.019_bb0190","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2019.01.019_bb0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/SAR.S22782","article-title":"Selective review and commentary on emerging pharmacotherapies for opioid addiction","volume":"2","author":"Ling","year":"2011","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1192\/pb.28.2.47","article-title":"Treatment preferences of opiate-dependent patients","volume":"28","author":"Luty","year":"2004","journal-title":"Psychiatric Bulletin"},{"key":"10.1016\/j.jsat.2019.01.019_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugpo.2017.07.025","article-title":"Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine","volume":"49","author":"Madden","year":"2017","journal-title":"The International Journal on Drug Policy"},{"issue":"8","key":"10.1016\/j.jsat.2019.01.019_bb0210","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/add.14198","article-title":"An investigation of an open-access model for scaling up methadone maintenance treatment","volume":"113","author":"Madden","year":"2018","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/add.13680","article-title":"Prioritizing the patient in patient-centered addictions treatment","volume":"112","author":"Marchand","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2019.01.019_bb0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsat.2018.01.003","article-title":"A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine","volume":"86","author":"Marcus","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.01.019_bb0225","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1016\/j.jsat.2019.01.019_bb0230","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2019.01.019_bb0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10742-014-0121-1","article-title":"Using the nominal group technique: How to analyse across multiple groups","volume":"14","author":"McMillan","year":"2014","journal-title":"Health Services & Outcomes Research Methodology"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0740-5472(02)00246-5","article-title":"Detoxification as a gateway to long-term treatment: Assessing two interventions","volume":"23","author":"Millery","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2019.01.019_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1016\/j.jsat.2019.01.019_bb0255","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5055\/jom.2010.0043","article-title":"The relationship between opioid and sugar intake: Review of evidence and clinical applications","volume":"6","author":"Mysels","year":"2010","journal-title":"Journal of Opioid Management"},{"issue":"5","key":"10.1016\/j.jsat.2019.01.019_bb0260","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2019.01.019_bb0265","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dar.12079","article-title":"Regaining control: The patient experience of supervised compared with unsupervised consumption in opiate substitution treatment","volume":"33","author":"Notley","year":"2014","journal-title":"Drug and Alcohol Review"},{"issue":"5","key":"10.1016\/j.jsat.2019.01.019_bb0270","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","article-title":"Barriers to use of pharmacotherapy for addiction disorders and how to overcome them","volume":"13","author":"Oliva","year":"2011","journal-title":"Current Psychiatry Reports"},{"issue":"14","key":"10.1016\/j.jsat.2019.01.019_bb0275","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jama.2014.2147","article-title":"Confronting the stigma of opioid use disorder\u2014and its treatment","volume":"311","author":"Olsen","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jsat.2019.01.019_bb0280","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.01.019_bb0285","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s10461-016-1375-0","article-title":"Attitudes toward addiction, methadone treatment, and recovery among HIV-infected Ukrainian prisoners who inject drugs: incarceration effects and exploration of mediators","volume":"20","author":"Polonsky","year":"2016","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2019.01.019_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1099-1050(200004)9:3<267::AID-HEC511>3.0.CO;2-H","article-title":"The veil of experience: Do consumers prefer what they know best?","volume":"9","author":"Salkeld","year":"2000","journal-title":"Health Economics"},{"issue":"14","key":"10.1016\/j.jsat.2019.01.019_bb0300","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004\u20132013","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2019.01.019_bb0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12913-015-1215-3","article-title":"The ideal healthcare: Priorities of people with chronic conditions and their carers","volume":"15","author":"Sav","year":"2015","journal-title":"BMC Health Services Research"},{"issue":"4","key":"10.1016\/j.jsat.2019.01.019_bb0310","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2019.01.019_bb0315","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/add.13622","article-title":"Patient-centered methadone treatment: A randomized clinical trial","volume":"112","author":"Schwartz","year":"2017","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.jsat.2019.01.019_bb0320","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2019.01.019_bb0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ypmed.2015.04.017","article-title":"Interim treatment: Bridging delays to opioid treatment access","volume":"80","author":"Sigmon","year":"2015","journal-title":"Preventive Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5055\/jom.2013.0152","article-title":"Consumer attitudes about opioid addiction treatment: A focus group study in New York City","volume":"9","author":"Sohler","year":"2013","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.jsat.2019.01.019_bb0335","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2019.01.019_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S45585","article-title":"New developments in the management of opioid dependence: Focus on sublingual buprenorphine-naloxone","volume":"6","author":"Soyka","year":"2015","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.jsat.2019.01.019_bb0345","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2015.10.023","article-title":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","volume":"157","author":"Springer","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2019.01.019_bb0350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","article-title":"Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV with opioid use disorders transitioning to the community: Results of a double-blind, placebo-controlled randomized trial","volume":"78","author":"Springer","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2019.01.019_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001431.pub4","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"1","author":"Stacey","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2019.01.019_bb0360","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2019.01.019_bb0365","article-title":"Medications for opioid use disorder","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.jsat.2019.01.019_bb0370","series-title":"Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration and Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"10.1016\/j.jsat.2019.01.019_bb0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients' beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2019.01.019_bb0380","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/S2214-109X(16)30303-5","article-title":"Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: A two-arm, prospective observational study","volume":"5","author":"Wegman","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"1","key":"10.1016\/j.jsat.2019.01.019_bb0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugpo.2010.08.001","article-title":"\u201cShould I stay or should I go?\u201d Coming off methadone and buprenorphine treatment","volume":"22","author":"Winstock","year":"2011","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2019.01.019_bb0390","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"14","key":"10.1016\/j.jsat.2019.01.019_bb0395","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/10826084.2016.1201117","article-title":"Acceptability of extended-release naltrexone by heroin-dependent patients and addiction treatment providers in the Netherlands","volume":"51","author":"Zaaijer","year":"2016","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2019.01.019_bb0400","series-title":"Unpublished manuscript submitted for publication","article-title":"Obstacles in eyes of beholders: Measuring multilevel barriers to substance abuse treatment entry among people who inject drugs in Ukraine","author":"Zelenev","year":"2018"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218304227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218304227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:48:56Z","timestamp":1760039336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547218304227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":80,"alternative-id":["S0740547218304227"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.01.019","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}